← TruNorth

CRISPR Therapeutics AG vs Dianthus Therapeutics, Inc.

On overall TruNorth grade, CRISPR Therapeutics AG scores higher (CRISPR Therapeutics AG: B, Dianthus Therapeutics, Inc.: C). Both graded from public records across nine values categories.

B
CRISPR Therapeutics AG
61.4/100
C
Dianthus Therapeutics, Inc.
55/100

Political donations

CRISPR Therapeutics AG

FEC: $380K in executive political donations; partisan lean split across 15 executive donors.

Dianthus Therapeutics, Inc.

FEC: $310K in executive political donations; partisan lean Democratic +23 across 9 executive donors.

Environment

CRISPR Therapeutics AG

No public record found.

Dianthus Therapeutics, Inc.

No public record found.

Labor

CRISPR Therapeutics AG

No public record found.

Dianthus Therapeutics, Inc.

No public record found.

DEI

CRISPR Therapeutics AG

No public record found.

Dianthus Therapeutics, Inc.

No public record found.

Charity

CRISPR Therapeutics AG

No public record found.

Dianthus Therapeutics, Inc.

No public record found.

Animal testing

CRISPR Therapeutics AG

No public record found.

Dianthus Therapeutics, Inc.

No public record found.

Firearms

CRISPR Therapeutics AG

No public record found.

Dianthus Therapeutics, Inc.

No public record found.

Privacy

CRISPR Therapeutics AG

No public record found.

Dianthus Therapeutics, Inc.

No public record found.

Executive pay

CRISPR Therapeutics AG

CEO total compensation $33.2M (2024; other named executives averaged $5.6M) — SEC pay-versus-performance disclosure (Item 402(v) XBRL).

Dianthus Therapeutics, Inc.

No public record found.

Compare any two brands on the values you care about — personalized to your 30-second quiz.

Open TruNorth →